TKM Market CapTekmira's market cap is now about equal to their cash on hand (i.e., $30 million). It would seem that the street is giving little value to their internal work or their projects/relationships with ALNY or Hana. Which is too bad because I still think RNAi is one of the more exciting fields (but yes still much proof is required). Also, Inex seems to have shown that their liposomes do actually help deliver drups better in other indications such that if RNAi works, it could really be a pivotal tool.
From my recent non-response from numerous inquiries, I am not sure that TKM's management is overly concerned with shareholders (I think they feel we are a necessary evil but do not need to respond to our concerns). But this does not justify the poor market cap.
I am still hopeful in their technology but I am beginning to wonder if some bad news may be leaking out somewhere...